Loading...
NPI 1942205935 · New Hartford, NY · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Joseph Gale is a ophthalmology physician provider located in New Hartford, New York. This profile covers 20 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Joseph Gale |
| Address | 4350 Middle Settlement Rd |
| City | New Hartford |
| State | NY |
| ZIP | 13413 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | June 16, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.4M |
| Medicaid | $213.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 2,700 | $690 | $1.9M |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,740 | $100 | $170.6K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 4,060 | $30 | $117.8K |
| J2778 | Injection, ranibizumab, 0.1 mg | 380 | $180 | $68K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 680 | $70 | $45.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,330 | $30 | $40K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 410 | $90 | $36.1K |
| J9035 | Injection, bevacizumab, 10 mg | 650 | $30 | $21.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 170 | $120 | $21.2K |
| 67042 | In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina… | 20 | $660 | $15.1K |
Showing 1–10 of 20
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
20 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 19 | 230 | 560 | $690 | $693K |
| J2777 | 91 | 120 | 7,740 | $30 | $364.9K |
| J2778 | 46 | 70 | 510 | $180 | $131.6K |
| 67028 | 26 | 300 | 400 | $100 | $65.9K |
| 92242 | 12 | 20 | 110 | $240 | $33K |
| 92014 | 541 | 2,220 | 160 | $100 | $29.3K |
| 67036 | 40 | 50 | 20 | $940 | $23.5K |
| 67042 | 9 | 40 | 20 | $1,030 | $22.7K |
| 92012 | 130 | 1,640 | 100 | $70 | $17.4K |
| 92235 | 42 | 190 | 60 | $120 | $14.1K |
Showing 1–10 of 20
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 290 | $450 | $130.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,860 | $30 | $57.6K |
| J9035 | Injection, bevacizumab, 10 mg | 880 | $10 | $12.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 990 | $10 | $7.9K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 380 | $10 | $3.8K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 70 | $30 | $1.7K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 50 | $10 | $470 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 50 | 100 | 280 | $650 | $369.9K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,826 | 2,440 | 330 | $70 | $92.6K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 674 | 1,460 | 310 | $60 | $88.1K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 44 | 260 | 420 | $70 | $65.6K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 1,170 | 1,490 | 340 | $40 | $48.7K |
| J9035 | Injection, bevacizumab, 10 mg | 29 | 150 | 170 | $80 | $36.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 233 | 730 | 370 | $20 | $30K |
Other providers in the same ZIP code as Joseph Gale, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Slocum Dickson Medical Group PLLC | NY | Clinic/Center | $0 | $53.9M |
| Manzurul Sikder | NY | Hematology & Oncology Physician | $2.3M | $91.6K |
| Aziz Basem Nicholas Qandah | NY | Neurological Surgery Physician | $859.6K | $132.5K |
| Sultana Razia | NY | Hematology & Oncology Physician | $806.2K | $89.9K |
| Dayal Raja | NY | Endocrinology, Diabetes & Metabolism Physician | $579.1K | $119.2K |
| Dana Zacharewicz | NY | Diagnostic Ultrasound Physician | $514.1K | $15.3K |
| Scott Peplinski | NY | Diagnostic Radiology Physician | $481.6K | $14.2K |
| Nathaniel Gould | NY | Physical Medicine & Rehabilitation Physician | $402.5K | $76.1K |
| Daniel Welchons | NY | Urology Physician | $435.9K | $5.8K |
| Mohsin Syed | NY | Internal Medicine Physician | $227.5K | $141.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.